Michael Ruse's Darwin and Design: Science, Philosophy, Religion explains the history and philosophical arguments of the design metaphor of evolution. It recounts the historical uses of the metaphor from Plato to twentieth‐century American science. Ruse explores the criticisms of the design metaphor and ultimately concludes that it is a beneficial term. The chief contribution of Darwin and Design is that it offers a clear understanding and comparison of the argument from design and the argument to design.

This essay explores the significance and implications of the causal theory of reference for the current debate on the necessity and exchangeability of the divine title ‘Father’ in the discourse of the Church. Identifying ‘Father’ as a vocative term historically grounded in the speech of Jesus and his Apostles, the authors assert that it successfully refers to God, functioning very much like a proper name. They also identify linguistic barriers to its replacement by other terms.

The validity of an argument depends on the soundness of its premises. In the recent paper by Steele et al., conclusions are based on the initial construction of definitions relating to ‘desire’ and...

Ecological crisis is being widely discussed in society today and therefore, the subject of religious naturalism has emerged as a major topic in religion. The Routledge Handbook of Religious Naturalism is an outstanding reference source to the key topics, problems, and debates in this exciting subject and is the first collection of its kind. Comprising thirty-four chapters by a team of international contributors, the Handbook is divided into seven parts: ¿ Varieties of religious naturalism and its relations to other outlooks (...) ¿ Some earlier religious naturalists ¿ Pantheism, materialism, and the value-ladenness of nature ¿ Ecology, humans, and politics in naturalistic perspective ¿ Religious naturalism and traditional religions ¿ Putting religious naturalism into practice ¿ Critical discussions of religious naturalism. Within these sections central issues, debates, and problems are examined, including: defining religious naturalism; religious underpinnings of ecology; natural piety; the religious-aesthetic; ecstatic naturalism as deep pantheism; spiritual ecology; African-American religious naturalism; Christian religious naturalism; Dao and water; Confucianism; environmental action; and practices in religious naturalism. The Routledge Handbook of Religious Naturalism is essential reading for students and researchers in religious studies, theology, and philosophy. The Handbook will also be useful for those in related fields, such as environmental ethics and ecology. (shrink)

Hospital systems commonly face the challenge of determining just ways to allocate scarce drugs during national shortages. There is no standardised approach of how this should be instituted, but principles of distributive justice are commonly used so that patients who are most likely to benefit from the drug receive it. As a result, clinical indications, in which the evidence for the drug is assumed to be established, are often prioritised over research use. In this manuscript, we present a case of (...) a phase II investigational trial of intravenous thiamine for delirium prevention in patients undergoing haematopoietic stem cell transplantation to emphasise several shortcomings in the overarching prioritisation of clinical over research uses of scarce drugs. Specifically, we present the following considerations: clinical use may not have stronger evidence than research use; a strong scientific rationale for research use may outweigh the claim for clinical indications in which there is weak evidence; treatment within the context of a clinical trial may be the standard of care; and research use may not only benefit patients receiving the treatment but also offers the prospect of improving future clinical care. In summary, we argue against allocation schemes that prohibit all research uses of scarce drugs and instead recommend that allocation schemes include a balanced approach that weighs risks and benefits of access to scarce drugs irrespective of the research versus clinical use designation. (shrink)